MoneyWorks4Me

Cipla concludes transfer of its entire stake in Biomab

25 Jan 2016 Evaluate

Cipla has completed the transfer formalities in relation to the divestment of its entire 25% stake held in Biomab Holding, Hong Kong (Biomab) on January 22, 2016. Consequently, the company ceases to hold any stake in Biomab.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally.


Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..